Newsroom

The Pharmaceutical Printed Literature Association (PPLA) is advocating for the retention of printed Prescribing Information (PI) and Patient Medication Information (PMI) amidst proposed FDA rules that could limit access. They emphasize that printed materials are vital for rural Americans lacking digital access, urging the Trump administration to protect these resources to ensure medication safety and… Read More

The Pharmaceutical Printed Literature Association (PPLA) urges Dr. Marty Makary to prioritize patient safety by reversing harmful FDA regulations on printed medication information if confirmed as commissioner. The proposed rules threaten crucial printed instructions for patients and pharmacists, compromising care and safety. PPLA advocates for accessible medication literature to enhance patient involvement. Read More

Following President Trump’s inauguration, PPLA Chairman Dave Joesten urged nominees Robert F. Kennedy Jr. and Dr. Marty Makary to rescind proposed FDA rules that would limit printed Prescribing and Patient Medication Information. These rules threaten patient safety, particularly for vulnerable populations, while a bipartisan coalition supports legislation for accessible printed information. Read More

On January 12th, National Pharmacist Day highlighted the crucial role pharmacists play amid a wave of pharmacy closures impacting millions of Americans. With 7,000 pharmacies closing since 2019, the FDA’s proposed rule on Patient Medication Information could exacerbate the crisis by increasing costs and workloads, threatening patient access to vital medication guidance. Read More

Since 2019, over 7,000 pharmacies have closed in the U.S., creating pharmacy deserts. This crisis emphasizes the need for accessible printed Patient Medication Information (PMI) for safe medication use. The FDA’s proposed rule limiting PMI access may exacerbate the issue, prompting bipartisan support for the Patients’ Right to Know Their Medication Act to ensure patients… Read More